Crescent Biopharma, Inc. (CBIO)

CIK 1253689 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Crescent Biopharma, Inc..

Recent SEC filings

FiledFormAccession number
Oct 27, 2026SCHEDULE 13G0002012383-26-003736
Oct 15, 20268-K0001628280-26-066006
Sep 18, 202640001628280-26-062706
Sep 18, 2026S-80001628280-26-062634
Sep 18, 202640001628280-26-062703
Sep 18, 202640001628280-26-062700
Sep 18, 202640001628280-26-062707
Sep 18, 202640001628280-26-062709
Sep 18, 202640001628280-26-062705
Sep 18, 202640001628280-26-062701
Sep 17, 20261440001628280-26-062526
Sep 17, 20261440001628280-26-062529
Sep 16, 20261440001628280-26-062211
Sep 16, 20261440001628280-26-062213
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003420
Jul 31, 2026EFFECT9999999995-26-002504
Jul 30, 2026424B30001628280-26-050881
Jul 30, 2026POS AM0001628280-26-050885
Jul 30, 20268-K0001628280-26-050805
Jul 30, 202610-Q0001628280-26-050869
Jul 20, 202640001104659-26-085113
Jul 20, 2026SCHEDULE 13D/A0001104659-26-085114
Jul 15, 2026424B50001628280-26-048344
Jul 15, 20268-K0001628280-26-048347
Jul 14, 2026424B50001628280-26-048144